MetaADEDB 2.0 @ LMMD
Dextromethorphan
(MISZALMBODQYFT-URVXVIKDSA-N)
Structure
SMILES
COc1ccc2c(c1)[C@@]13CCCC[C@@H]3[C@H](C2)N(CC1)C.Br
Molecular Formula:
C18H26BrNO
Molecular Weight:
352.309
Log P:
4.2794
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
12.47
CAS Number(s):
125-69-9; 6700-34-1
Synonym(s)
1.
Dextromethorphan
2.
d-Methorphan
3.
Delsym
4.
Dextromethorphan Hydrobromide
5.
Dextromethorphan Hydrobromide, (+-)-Isomer
6.
Dextromethorphan Hydrobromide, Monohydrate
7.
Dextromethorphan Hydrochloride
8.
Dextromethorphan, (+-)-Isomer
9.
Levomethorphan
10.
Racemethorphan
11.
l-Methorphan
12.
Hydrobromide, Dextromethorphan
13.
Hydrochloride, Dextromethorphan
External Link(s)
MeSHD003915
PubChem Compound5464025
CHEMBLCHEMBL1201004
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 956
Canada Vigilance: 6
Canada Vigilance
US FAERS
2OverdoseFAERS: 240
Canada Vigilance: 1
Canada Vigilance
US FAERS
3No adverse eventFAERS: 212US FAERS
4Accidental overdoseFAERS: 167US FAERS
5DizzinessFAERS: 166US FAERS
6Drug abuseFAERS: 129
Canada Vigilance: 1
Canada Vigilance
US FAERS
7SomnolenceFAERS: 80US FAERS
8Feeling abnormalFAERS: 77US FAERS
9NauseaFAERS: 74US FAERS
10VomitingFAERS: 69US FAERS
11Accidental exposure to product by childFAERS: 67US FAERS
12Drug administered to patient of inappropriate ageFAERS: 64US FAERS
13Inappropriate schedule of drug administrationFAERS: 62US FAERS
14HeadacheFAERS: 56US FAERS
15Incorrect drug administration durationFAERS: 41US FAERS
16Incorrect dose administeredFAERS: 39US FAERS
17MalaiseFAERS: 39US FAERS
18MydriasisFAERS: 39US FAERS
19FatigueFAERS: 36US FAERS
20Abdominal discomfortFAERS: 34US FAERS
21HypersensitivityFAERS: 34US FAERS
22Drug effect incompleteFAERS: 32US FAERS
23Euphoric moodFAERS: 31US FAERS
24UrticariaFAERS: 30US FAERS
25Expired product administeredFAERS: 27US FAERS
26Blood glucose increasedFAERS: 26US FAERS
27PruritusFAERS: 22US FAERS
28TremorFAERS: 22US FAERS
29AgitationFAERS: 21US FAERS
30Product taste abnormalFAERS: 19US FAERS
31AnxietyFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
32DisorientationFAERS: 17US FAERS
33Drug DependenceFAERS: 17US FAERS
34AstheniaFAERS: 16US FAERS
35DysarthriaFAERS: 16US FAERS
36Toxicity to various agentsFAERS: 16US FAERS
37NervousnessFAERS: 15US FAERS
38Unevaluable eventFAERS: 15US FAERS
39LethargyFAERS: 13US FAERS
40PalpitationsFAERS: 13US FAERS
41RestlessnessFAERS: 13US FAERS
42ErythemaFAERS: 12US FAERS
43Incorrect product administration durationFAERS: 12US FAERS
44Product use issueFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Drug toxicityFAERS: 11US FAERS
46Feeling jitteryFAERS: 11US FAERS
47RetchingFAERS: 11US FAERS
48Wrong technique in product usage processFAERS: 11US FAERS
49Inappropriate schedule of product administrationFAERS: 10US FAERS
50Throat irritationFAERS: 10US FAERS
51Accidental drug intake by childFAERS: 9US FAERS
52AtaxiaFAERS: 9US FAERS
53Chest PainFAERS: 9US FAERS
54ConstipationFAERS: 9US FAERS
55Intentional drug misuseFAERS: 9US FAERS
56Product administered to patient of inappropriate ageFAERS: 9US FAERS
57SyncopeFAERS: 9US FAERS
58Abdominal PainFAERS: 8US FAERS
59Medication ErrorFAERS: 8US FAERS
60Product quality issueFAERS: 8US FAERS
61TachycardiaFAERS: 8US FAERS
62VertigoFAERS: 8US FAERS
63Visual ImpairmentFAERS: 8US FAERS
64Completed SuicideFAERS: 7US FAERS
65Drug abuserFAERS: 7US FAERS
66Extra dose administeredFAERS: 7US FAERS
67Feeling ColdFAERS: 7US FAERS
68FlushingFAERS: 7US FAERS
69PainFAERS: 7US FAERS
70StuporFAERS: 7US FAERS
71TinnitusFAERS: 7US FAERS
72Unresponsive to stimuliFAERS: 7US FAERS
73DeliriumFAERS: 6US FAERS
74Depressed Level of ConsciousnessFAERS: 6US FAERS
75DiscomfortFAERS: 6US FAERS
76DysphoniaFAERS: 6US FAERS
77DysuriaFAERS: 6US FAERS
78FlatulenceFAERS: 6US FAERS
79Head discomfortFAERS: 6US FAERS
80Musculoskeletal stiffnessFAERS: 6US FAERS
81NystagmusFAERS: 6US FAERS
82ParanoiaFAERS: 6US FAERS
83AmnesiaFAERS: 5US FAERS
84Chest discomfortFAERS: 5US FAERS
85Circumstance or information capable of leading to medication errorFAERS: 5US FAERS
86DehydrationFAERS: 5US FAERS
87DyspepsiaFAERS: 5US FAERS
88EpistaxisFAERS: 5US FAERS
89Lip swellingFAERS: 5US FAERS
90Mental impairmentFAERS: 5US FAERS
91Mental status changesFAERS: 5US FAERS
92Oropharyngeal painFAERS: 5US FAERS
93PoisoningFAERS: 5US FAERS
94Product label issueFAERS: 5US FAERS
95WheezingFAERS: 5US FAERS
96Wrong drug administeredFAERS: 5US FAERS
97Activities of daily living impairedFAERS: 4US FAERS
98Adverse eventFAERS: 4US FAERS
99Bipolar DisorderFAERS: 4US FAERS
100BronchitisFAERS: 4US FAERS
101Burning sensationFAERS: 4US FAERS
102Cardiac ArrestFAERS: 4US FAERS
103Cerebrovascular accidentFAERS: 4US FAERS
104Cold sweatFAERS: 4US FAERS
105DissociationFAERS: 4US FAERS
106Drug screen positiveFAERS: 4US FAERS
107Drug withdrawal syndromeFAERS: 4US FAERS
108HypotensionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
109IncoherentFAERS: 4US FAERS
110PresyncopeFAERS: 4US FAERS
111Product lot number issueFAERS: 4US FAERS
112Serotonin SyndromeFAERS: 4US FAERS
113Altered state of consciousnessFAERS: 3US FAERS
114Anaphylactic shockFAERS: 3US FAERS
115AnosmiaFAERS: 3US FAERS
116AphoniaFAERS: 3US FAERS
117AsthmaFAERS: 3US FAERS
118Drug exposure during pregnancyFAERS: 3US FAERS
119DysgeusiaFAERS: 3US FAERS
120DystoniaFAERS: 3US FAERS
121HyperventilationFAERS: 3US FAERS
122HypervigilanceFAERS: 3US FAERS
123InfluenzaFAERS: 3US FAERS
124Intentional product use issueFAERS: 3US FAERS
125Loss of personal independence in daily activitiesFAERS: 3US FAERS
126PallorFAERS: 3US FAERS
127Peripheral swellingFAERS: 3US FAERS
128Pharmaceutical product complaintFAERS: 3US FAERS
129PhotophobiaFAERS: 3US FAERS
130Product expiration date issueFAERS: 3US FAERS
131Product packaging issueFAERS: 3US FAERS
132Product use complaintFAERS: 3US FAERS
133Productive CoughFAERS: 3US FAERS
134SwellingFAERS: 3US FAERS
135Therapeutic response unexpectedFAERS: 3US FAERS
136Accidental exposure to productFAERS: 2US FAERS
137Accidental exposureFAERS: 2US FAERS
138Acute kidney injuryFAERS: 2US FAERS
139AgeusiaFAERS: 2US FAERS
140Altered visual depth perceptionFAERS: 2US FAERS
141AnorexiaFAERS: 2US FAERS
142AutoscopyFAERS: 2US FAERS
143Blood glucose decreasedFAERS: 2US FAERS
144ChillsFAERS: 2US FAERS
145ChromaturiaFAERS: 2US FAERS
146Contraindicated product administeredFAERS: 2US FAERS
147CryingFAERS: 2US FAERS
148DependenceFAERS: 2US FAERS
149DiplopiaFAERS: 2US FAERS
150Drug ToleranceFAERS: 2US FAERS
151Drug effect delayedFAERS: 2US FAERS
152Drug screen false positiveFAERS: 2US FAERS
153Eye painFAERS: 2US FAERS
154Failure of child resistant mechanism for pharmaceutical productFAERS: 2US FAERS
155Feeling of body temperature changeFAERS: 2US FAERS
156Foaming at mouthFAERS: 2US FAERS
157GlaucomaFAERS: 2US FAERS
158Hallucinations, mixedFAERS: 2US FAERS
159HyperreflexiaFAERS: 2US FAERS
160Impaired driving abilityFAERS: 2US FAERS
161Inappropriate affectFAERS: 2US FAERS
162Intentional self-injuryFAERS: 2US FAERS
163Memory impairmentFAERS: 2US FAERS
164Muscle RigidityFAERS: 2US FAERS
165Nasal discomfortFAERS: 2US FAERS
166NephrolithiasisFAERS: 2US FAERS
167Paradoxical drug reactionFAERS: 2US FAERS
168Physical assaultFAERS: 2US FAERS
169PneumoniaFAERS: 2US FAERS
170Product complaintFAERS: 2US FAERS
171Product formulation issueFAERS: 2US FAERS
172Product use in unapproved indicationFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
173Reaction to preservativesFAERS: 2US FAERS
174Respiratory arrestFAERS: 2US FAERS
175SinusitisFAERS: 2US FAERS
176Slow response to stimuliFAERS: 2US FAERS
177SneezingFAERS: 2US FAERS
178Status AsthmaticusFAERS: 2US FAERS
179StillbirthFAERS: 2US FAERS
180StressFAERS: 2US FAERS
181TensionFAERS: 2US FAERS
182Urinary RetentionFAERS: 2US FAERS
183Vocal Cord ParalysisFAERS: 2US FAERS
184Weight decreasedFAERS: 2US FAERS
185nervous system disorderFAERS: 2US FAERS
186AbasiaFAERS: 1US FAERS
187Abdominal massFAERS: 1US FAERS
188Accidental deathFAERS: 1US FAERS
189AcneFAERS: 1US FAERS
190Alcohol poisoningFAERS: 1US FAERS
191Allergic reaction to excipientFAERS: 1US FAERS
192AngerFAERS: 1US FAERS
193AnhedoniaFAERS: 1US FAERS
194AnorgasmiaFAERS: 1US FAERS
195Apparent life threatening eventFAERS: 1US FAERS
196ArthralgiaFAERS: 1US FAERS
197ArthritisFAERS: 1US FAERS
198Atrial FibrillationFAERS: 1US FAERS
199Back PainFAERS: 1US FAERS
200Biopsy liver abnormalFAERS: 1US FAERS
201Bipolar I disorderFAERS: 1US FAERS
202BlepharospasmFAERS: 1US FAERS
203Blood urine presentFAERS: 1US FAERS
204Bowel movement irregularityFAERS: 1US FAERS
205CatatoniaFAERS: 1US FAERS
206CellulitisFAERS: 1US FAERS
207Cerebral ThrombosisFAERS: 1US FAERS
208Cerebral disorderFAERS: 1US FAERS
209Choking sensationFAERS: 1US FAERS
210ChokingFAERS: 1US FAERS
211CyanosisFAERS: 1US FAERS
212DeformityFAERS: 1US FAERS
213Depressed moodFAERS: 1US FAERS
214Diabetes MellitusFAERS: 1US FAERS
215Dissociative disorderFAERS: 1US FAERS
216Documented hypersensitivity to administered drugFAERS: 1US FAERS
217Dreamy stateFAERS: 1US FAERS
218Drug administered in wrong deviceFAERS: 1US FAERS
219Drug administration errorFAERS: 1US FAERS
220Drug dose omissionFAERS: 1US FAERS
221Ear discomfortFAERS: 1US FAERS
222Economic problemFAERS: 1US FAERS
223Elevated moodFAERS: 1US FAERS
224Emergency CareFAERS: 1US FAERS
225Erectile dysfunctionFAERS: 1US FAERS
226Facial PainFAERS: 1US FAERS
227Facial paralysisFAERS: 1US FAERS
228Food PoisoningFAERS: 1US FAERS
229FormicationFAERS: 1US FAERS
230GastritisFAERS: 1US FAERS
231Gastrointestinal sounds abnormalFAERS: 1US FAERS
232General physical condition abnormalFAERS: 1US FAERS
233Guillain-Barre SyndromeFAERS: 1US FAERS
234HemiparesisFAERS: 1US FAERS
235HungerFAERS: 1US FAERS
236HyperacusisFAERS: 1US FAERS
237HypersomniaFAERS: 1US FAERS
238HyporeflexiaFAERS: 1US FAERS
239HypoxiaFAERS: 1US FAERS
240Impaired work abilityFAERS: 1US FAERS
241Incorrect dose administered by deviceFAERS: 1US FAERS
242Increased viscosity of bronchial secretionFAERS: 1US FAERS
243InfectionFAERS: 1US FAERS
244Initial insomniaFAERS: 1US FAERS
245Intentional product misuseFAERS: 1US FAERS
246Intercepted medication errorFAERS: 1US FAERS
247Joint swellingFAERS: 1US FAERS
248LacerationFAERS: 1US FAERS
249Lacrimation decreasedFAERS: 1US FAERS
250Limb discomfortFAERS: 1US FAERS
251Liquid product physical issueFAERS: 1US FAERS
252Lower respiratory tract infectionFAERS: 1US FAERS
253MacrocytosisFAERS: 1US FAERS
254Mouth swellingFAERS: 1US FAERS
255Muscle strainFAERS: 1US FAERS
256MyalgiaFAERS: 1US FAERS
257Myocardial InfarctionFAERS: 1US FAERS
258Neck PainFAERS: 1US FAERS
259Night sweatsFAERS: 1US FAERS
260OpisthotonusFAERS: 1US FAERS
261Patient-device incompatibilityFAERS: 1US FAERS
262PetechiaeFAERS: 1US FAERS
263Phobia of drivingFAERS: 1US FAERS
264Pleuritic painFAERS: 1US FAERS
265PolyuriaFAERS: 1US FAERS
266Poor quality sleepFAERS: 1US FAERS
267Product barcode issueFAERS: 1US FAERS
268Product container issueFAERS: 1US FAERS
269Product contamination physicalFAERS: 1US FAERS
270Product label confusionFAERS: 1US FAERS
271Product outer packaging issueFAERS: 1US FAERS
272Product packaging quantity issueFAERS: 1US FAERS
273Product physical consistency issueFAERS: 1US FAERS
274Product tamperingFAERS: 1US FAERS
275Rash erythematousFAERS: 1US FAERS
276Reaction to drug excipientsFAERS: 1US FAERS
277Reaction to food additiveFAERS: 1US FAERS
278RegurgitationFAERS: 1US FAERS
279Renal painFAERS: 1US FAERS
280Respiratory distressFAERS: 1US FAERS
281Respiratory tract congestionFAERS: 1US FAERS
282RhabdomyolysisFAERS: 1US FAERS
283Saliva alteredFAERS: 1US FAERS
284ScreamingFAERS: 1US FAERS
285Skin irritationFAERS: 1US FAERS
286Slow speechFAERS: 1US FAERS
287SomnambulismFAERS: 1US FAERS
288Spinal cord herniationFAERS: 1US FAERS
289StaringFAERS: 1US FAERS
290StridorFAERS: 1US FAERS
291Sudden onset of sleepFAERS: 1US FAERS
292Tardive DyskinesiaFAERS: 1US FAERS
293Therapeutic product ineffectiveFAERS: 1US FAERS
294ThirstFAERS: 1US FAERS
295Tongue eruptionFAERS: 1US FAERS
296Tongue erythemaFAERS: 1US FAERS
297TonsillitisFAERS: 1US FAERS
298ToothacheFAERS: 1US FAERS
299TorticollisFAERS: 1US FAERS
300Transient aphasiaFAERS: 1US FAERS
301Tympanic Membrane PerforationFAERS: 1US FAERS
302UnemploymentFAERS: 1US FAERS
303Unmasking of previously unidentified diseaseFAERS: 1US FAERS
304Upper-airway cough syndromeFAERS: 1US FAERS
305Urinary IncontinenceFAERS: 1US FAERS
306Urine flow decreasedFAERS: 1US FAERS
307Visual disturbanceFAERS: 1US FAERS
308Wound ComplicationFAERS: 1US FAERS
309Wrong doseFAERS: 1US FAERS
310HyperpyrexiaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120330

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.